News

ICYMI, this week’s edition features a video series on social media use in dermatology, the launch of our new podcast, as well as articles about FDA approvals for acne and cSCC, progress in epidermolysis bullosa, new rosacea management treatment, plus more.

The U.S. Food and Drug Administration has approved the Abbreviated New Drug Application for topical retinoid adapalene gel USP, 0.3% from Alembic Pharmaceuticals and its joint venture Aleor Dermaceuticals for treatment of acne vulgaris.

In the final installment of our conversation with Adam Friedman, M.D., FAAD, he details what dermatologists should keep in mind when posting to social media.

Tazarotene lotion 0.045% (Arazlo, Ortho Dermatologics) is officially launched in the U.S. following approval by the U.S. Food and Drug Administration in late 2019 for the treatment of acne vulgaris in patients 9 years and older.

In part three of our video interview with Adam Friedman, M.D., FAAD, he discusses some of the benefits and pitfalls of colleague-to-colleague engagement on social media.

The U.S. Food and Drug Administration has approved pembrolizumab for cutaneous squamous cell carcinoma whose disease has shown to not be curable by radiation or surgery.

In our first episode of The Cutaneous Connection, Adam Friedman, M.D., FAAD, discusses his recent presentation at the first virtual American Academy of Dermatology meeting about cannabinoids use in dermatology.

In part two of our conversation with Adam Friedman, M.D., FAAD, he offers insight on which patients look for a dermatologist on social media and what types of content produce the most engagement online.

Gusacitinib, an investigational oral Janus kinase/spleen tyrosine kinase inhibitor, demonstrated statistical superiority compared with placebo for improving chronic hand eczema in a phase 2b study.

In this week's edition, we feature stories about dry brushing, the difference between psoriasis and eczema, comedone extractors, at-home microneedling, plus more.

ICYMI, this week’s edition features articles about laser therapy for BCC, the growing interest in JAK-STAT inhibition, tips on how to sell your practice, apremilast for scalp pruritus, plus more.

Evidence Skincare is now offering consumers a complementary skin survey to help identify consumers' problem areas, recommend skincare regimens and provide suggestions on what products might work best for them.

The Inaugural Pediatric Dermatology 2020: Best Practices and Innovations Conference is now open for registration and scheduled to take place June 27th, offering seven free CME credits.

A startup from Purdue University seeks to make handwashing easier and more accessible during COVID-19 through its new portable bedside sink technology developed by Project Process.

In this week’s edition, we feature stories about black-owned skincare lines, polyglutamic acid, hair antioxidants, a skincare company making affordable custom topical prescriptions, plus many more.

ICYMI, we've curated a list of all the stories we've published throughout the past week. Check out this article for more Dermatology Times content.

LEO Pharma will soon begin marketing its monoclonal antibody tralokinumab for atopic dermatitis with the announcement that the EMA has accepted the marketing authorization application for the drug.

Dermavant announces the enrollment completion for their long-term safety study investigating tapinarof in adults with plaque psoriasis as a part of the PSOARING 1 and PSOARING 2 phase 3 program.

AAD announces two physicians are recipients of the "Patient Care Hero" award for their work in implementing a teledermatology program in the U.S. Army program two decades ago.

In part two of our interview with Iltefat H. Hamzavi, M.D., he delves into the data from a recent article investigating the use ultraviolet germicidal irradiation (UVGI) as a method to disinfect N95 respirators for reuse during the COVID-19 pandemic.

In this webinar, moderated by Daniel Siegel, M.D., M.A., FAAD, FACMS, experts discuss guidance on the use of teledermatology and ways to successfully implement new models of care during the COVID-19 pandemic.

Eighteen residents and fellows in the throes of their dermatology training volunteered at the frontlines of overwhelmed Bronx-based hospitals during the height of the COVID-19 pandemic, gaining a crash course in crisis medicine and infectious diseases.

In the COVID-19 era, standard of care is still evolving. David J. Goldberg, M.D., J.D., discusses this and more liability issues to consider when re-opening your practice.

In part one of our video interview with Iltefat H. Hamzavi, M.D., he discusses how ultraviolet germicidal irradiation is used in dermatology and how it can be used to disinfect N95 respirators to facilitate reuse during the COVID-19 pandemic.

ForBabs introduces their X-Static hairbrush that keeps fly-aways and frizz at bay.

In this week’s edition, we highlight stories about ways to support people of color in the beauty industry aside from purchasing products, the safety of LED light therapy, dermaplaning at home, why your skin might be acting up right now, plus more.

Efforts are underway to identify new therapeutic methods that can offer improved outcomes for patients with hidradenitis suppurativa.

Efforts are underway to identify new therapeutic methods that can offer improved outcomes for patients with hidradenitis suppurativa.

In case you missed it, this week we featured stories involving blastic plasmacytoid dendritic cell neoplasm (BPDCN), development of a biosimilar to BOTOX, a new nonmelanoma treatment device, the latest phase 3 results for abrocitinib in atopic dermatitis, results from a long-term dabrafenib and trametinib study in stage 3 BRAF-mutated melanoma, plus many more.

In honor of June being Acne Awareness Month, Thayers has launched a new line of acne-tailored skincare products.